|
Activity Number:
|
97
|
|
Type:
|
Topic Contributed
|
|
Date/Time:
|
Monday, August 7, 2006 : 8:30 AM to 10:20 AM
|
|
Sponsor:
|
ENAR
|
| Abstract - #306930 |
|
Title:
|
Delivering Robust Outcomes from Multiregional Clinical Trials
|
|
Author(s):
|
Yoko Tanaka*+
|
|
Companies:
|
Eli Lilly and Company
|
|
Address:
|
Lilly Corporate Center, DC 6166, Indianpolis, IN, 46285,
|
|
Keywords:
|
heterogeneity ; multi-regional ; generalizability
|
|
Abstract:
|
Principles and strategies are considered for addressing heterogeneity due to geographic diversity in multiregional clinical trials. This diversity can be the result of differences in race, culture, standard of care, and/or quality of data across regions---each of which will be discussed. In light of these various sources of variability, we will consider implications of global data to specific regions and the generalizability of results. An important focus throughout will be the question of what constitutes an internally consistent global trial.
|
- The address information is for the authors that have a + after their name.
- Authors who are presenting talks have a * after their name.
Back to the full JSM 2006 program |
